Emerald Advisers »

Miragen Therapeutics shares owned by Emerald Advisers

Quarter-by-quarter ownership of Miragen Therapeutics (VRDN) shares owned by Emerald Advisers from 13F filings

Historical chart of Emerald Advisers investment in Miragen Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Miragen Therapeutics held by Emerald Advisers consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Miragen Therapeutics by Emerald Advisers

Quarter filed Position value Share count Share price at filing
2026-06-30 $9.9M 537k 18.37

More positions owned by Emerald Advisers

Travere Therapeutics (TVTX)
Cardinal Infrastructure Grou (CDNL)
Mercury Computer Systems (MRCY)
Aar (AIR)
VSE Corporation (VSEC)
Kulicke and Soffa Industries (KLIC)
Argan (AGX)
CECO Environmental (CECO)
Corcept Therapeutics Incorporated (CORT)
Livanova Plc Ord (LIVN)
Semtech Corporation (SMTC)
InterDigital (IDCC)
ESCO Technologies (ESE)
Axcelis Technologies (ACLS)
PDF Solutions (PDFS)

View all positions for Emerald Advisers

Top funds holding Miragen Therapeutics

FMR
BlackRock
Bellevue Group
Paradigm Biocapital Advisors
Kynam Capital Management
Fairmount Funds Management
State Street Corporation
Vanguard Capital Management
Deep Track Capital
VR Adviser
T. Rowe Price Associates
Wellington Management Company
Vanguard Portfolio Management
Geode Capital Management
venBio Select Advisor

View all funds holding Miragen Therapeutics